Kyverna Therapeutics (KYTX) is rated a strong buy with promising KYV-101 Phase 2 data and near-term catalysts. Read here for ...

Russia has spent over 30 years developing the Arena-M active protection system for its tanks, with hopes of making them ...

Eternalisms: a tribute to the indefatigable husband and wife pair, whose art was a neverending process of revelation ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued ...

A sprawling fraud trial involving former premier Joseph Muscat lays bare the costs of 12 years of gangbuster growth.

As the workers’ compensation reforms return to parliament, a report has found NSW has the second most expensive scheme in ...

Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders ...

From major breakthroughs to karmic paybacks, 2026 is a year of transformation for all 12 zodiac signs. Here’s what the ...

In recent years, one abundantly clear trend has been the prominence of high-performance off-road technology and vehicles ...

TWO men have been jailed for playing leading roles in an operation to supply the class A drug tetrahydrocannabinol and to launder the proceeds through the banking system. Accomplices and long-time ...